Table 2.
Predictive factors for improvement of dysphagia score to ≤ 1 on univariate and multivariate logistic regression analyses
| Univariate analysis | Multivariate analysis | ||||||
|---|---|---|---|---|---|---|---|
| OR | 95% CI | P Value | OR | 95% CI | P Value | ||
| Age (years) |
< 75 ≥ 75 |
1 5.75 |
- 1.04–31.70 |
- 0.04 |
1 0.85 |
- 0.08–8.73 |
- 0.89 |
| Sex |
Male Female |
1 0.28 |
- 0.05–1.62 |
- 0.15 |
|||
| BMI, kg/m2 |
≥ 18.5 < 18.4 |
1 0.69 |
- 0.22–2.22 |
- 0.54 |
|||
| ECOG PS |
2 3–4 |
1 0.42 |
- 0.13–1.39 |
- 0.16 |
|||
| Pathology |
SCC Others |
1 1.30 |
- 0.20–8.59 |
- 0.79 |
|||
| Comorbidity index |
0 ≥ 1 |
1 0.96 |
- 0.30–3.08 |
- 0.94 |
|||
| Clinical T stage* |
cT3 cT4 |
1 0.27 |
- 0.08–0.92 |
- 0.04 |
1 0.36 |
- 0.07–1.94 |
- 0.24 |
| Clinical N stage* |
N0 N1-3 |
1 1.25 |
- 0.31–5.08 |
- 0.76 |
|||
| Clinical M stage* |
M0 M1 |
1 0.59 |
- 0.18–1.90 |
- 0.38 |
|||
| Dysphagia score |
2 3–4 |
1 0.25 |
- 0.07–0.88 |
- 0.03 |
1 0.16 |
- 0.03–0.94 |
- 0.04 |
| Primary tumor length, cm |
< 7.0 ≥ 7.0 |
1 0.37 |
- 0.11–1.26 |
- 0.11 |
|||
| Number of metastatic sites |
0–1 ≥ 2 |
1 0.63 |
- 0.16–2.44 |
- 0.50 |
|||
| Primary tumor location |
Thoracic GEJ |
1 0.52 |
- 0.08–3.46 |
- 0.50 |
|||
| GPS |
0 1–2 |
1 0.10 |
- 0.03–0.39 |
- < 0.01 |
1 0.07 |
- 0.01–0.40 |
- < 0.01 |
*Cancer staging followed the Union for International Cancer Control 8th edition guidelines. OR: odds ratio; CI: confidence interval; BMI: body mass index; ECOG PS: Eastern Cooperative Oncology Group performance status; SCC: squamous cell carcinoma; GEJ: gastro-esophageal junction; GPS: Glasgow Prognostic Score